The role of p66Shc in T2DM is highly inconclusive with conflicting results obtained in mouse models, however, higher levels of p66Shc expression are believed to suppress insulin signaling pathways, induce pancreatic β-cell apoptosis and reduce insulin secretion (73, 74). This evidence concerns the gene INS and type 2 diabetes mellitus.